Treace Medical Concepts, Inc. Files 2023 Annual Report (10-K)

Ticker: TMCI · Form: 10-K · Filed: 2024-02-27T00:00:00.000Z

Sentiment: neutral

Topics: 10-K, Treace Medical Concepts, Medical Devices, Financial Report, SEC Filing

TL;DR

<b>Treace Medical Concepts, Inc. has filed its 2023 10-K annual report, detailing its financial performance and business operations.</b>

AI Summary

TREACE MEDICAL CONCEPTS, INC. (TMCI) filed a Annual Report (10-K) with the SEC on February 27, 2024. Filed 10-K for the fiscal year ending December 31, 2023. Company incorporated in Florida (FL). Business and mailing address: 100 Palmetto Park Place, Ponte Vedra, FL 32081. Business phone number: (904) 373-5940. Standard Industrial Classification: Surgical & Medical Instruments & Apparatus [3841].

Why It Matters

For investors and stakeholders tracking TREACE MEDICAL CONCEPTS, INC., this filing contains several important signals. This filing provides a comprehensive overview of the company's financial health, operational risks, and strategic direction for the past fiscal year. Investors and analysts can use this report to assess the company's performance, evaluate its market position, and make informed investment decisions.

Risk Assessment

Risk Level: medium — TREACE MEDICAL CONCEPTS, INC. shows moderate risk based on this filing. The company operates in the medical device industry, which is subject to significant regulatory oversight and competitive pressures, as indicated by its SIC code and the nature of its business.

Analyst Insight

Review the detailed financial statements and risk factors in the 10-K to understand Treace Medical Concepts' current financial standing and future outlook.

Key Numbers

Key Players & Entities

FAQ

When did TREACE MEDICAL CONCEPTS, INC. file this 10-K?

TREACE MEDICAL CONCEPTS, INC. filed this Annual Report (10-K) with the SEC on February 27, 2024.

What is a 10-K filing?

A 10-K is a comprehensive annual financial report required by the SEC, covering audited financials, business operations, risk factors, and management discussion. This particular 10-K was filed by TREACE MEDICAL CONCEPTS, INC. (TMCI).

Where can I read the original 10-K filing from TREACE MEDICAL CONCEPTS, INC.?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by TREACE MEDICAL CONCEPTS, INC..

What are the key takeaways from TREACE MEDICAL CONCEPTS, INC.'s 10-K?

TREACE MEDICAL CONCEPTS, INC. filed this 10-K on February 27, 2024. Key takeaways: Filed 10-K for the fiscal year ending December 31, 2023.. Company incorporated in Florida (FL).. Business and mailing address: 100 Palmetto Park Place, Ponte Vedra, FL 32081..

Is TREACE MEDICAL CONCEPTS, INC. a risky investment based on this filing?

Based on this 10-K, TREACE MEDICAL CONCEPTS, INC. presents a moderate-risk profile. The company operates in the medical device industry, which is subject to significant regulatory oversight and competitive pressures, as indicated by its SIC code and the nature of its business.

What should investors do after reading TREACE MEDICAL CONCEPTS, INC.'s 10-K?

Review the detailed financial statements and risk factors in the 10-K to understand Treace Medical Concepts' current financial standing and future outlook. The overall sentiment from this filing is neutral.

How does TREACE MEDICAL CONCEPTS, INC. compare to its industry peers?

The company operates within the Surgical & Medical Instruments & Apparatus industry.

Are there regulatory concerns for TREACE MEDICAL CONCEPTS, INC.?

The filing is a 10-K, which is an annual report required by the U.S. Securities and Exchange Commission (SEC) for public companies.

Industry Context

The company operates within the Surgical & Medical Instruments & Apparatus industry.

Regulatory Implications

The filing is a 10-K, which is an annual report required by the U.S. Securities and Exchange Commission (SEC) for public companies.

What Investors Should Do

  1. Analyze the company's financial performance for the fiscal year ended December 31, 2023.
  2. Identify any significant risk factors disclosed in the filing that could impact future operations.
  3. Review the business description to understand Treace Medical Concepts' market and products.

Year-Over-Year Comparison

This is the initial filing data extracted from the provided text, and no prior filing data is available for comparison.

Filing Stats: 4,433 words · 18 min read · ~15 pages · Grade level 16.2 · Accepted 2024-02-27 16:29:40

Key Financial Figures

Filing Documents

Business

Business 3 Item 1A.

Risk Factors

Risk Factors 28 Item 1B. Unresolved Staff Comments 61 Item 1C. Cybersecurity 61 Item 2.

Properties

Properties 62 Item 3.

Legal Proceedings

Legal Proceedings 62 Item 4. Mine Safety Disclosures 62 PART II Item 5. Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 62 Item 6. [Reserved] 63 Item 7.

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 64 Item 7A.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 74 Item 8.

Financial Statements and Supplementary Data

Financial Statements and Supplementary Data 75 Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure 103 Item 9A.

Controls and Procedures

Controls and Procedures 103 Item 9B. Other Information 105 Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 105 PART III Item 10. Directors, Executive Officers and Corporate Governance 106 Item 11.

Executive Compensation

Executive Compensation 106 Item 12.

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters

Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters 106 Item 13. Certain Relationships and Related Transactions, and Director Independence 106 Item 14. Principal Accountant Fees and Services 106 PART IV Item 15. Exhibits, Financial Statement Schedules 107 Item 16. Form 10-K Summary 109

Signatures

Signatures 110 i SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS As used in this Annual Report on Form 10-K ("Annual Report"), unless expressly indicated or the context otherwise requires, references to "Treace Medical Concepts," "we," "us," "our," or "the Company," refer to Treace Medical Concepts, Inc. This Annual Report contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as codified in Section 27A of the Securities Act of 1933, as amended (the "Securities Act"), and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act") concerning our business, operations and financial performance and condition, as well as our plans, objectives and expectations for our business, operations and financial performance and condition. Any statements contained herein that are not statements of historical facts may be deemed to be forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "anticipate," "assume," "believe," "contemplate," "continue," "could," "due," "estimate," "expect," "goal," "intend," "may," "objective," "plan," "predict," "potential," "positioned," "seek," "should," "target," "will," "would" and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology. These forward-looking statements include, but are not limited to, statements about: the expected use of our products by physicians; the expected growth of our business and our organization; our plans and expected timeline related to our products, or developing or acquiring new products, to address additional indications or otherwise; our expectations regarding government and third-party payor coverage and reimbursement; our estimates of our expenses, ongoing losses, future revenue, capital requirements and our need for, or ability to obtain, additional financi

View on Read The Filing